American Healthcare REIT filings document the reporting framework for a NYSE-listed healthcare REIT with common stock and an operating partnership. Recent 8-K reports furnish earnings releases, financial-position updates, supplemental operating data, distribution authorizations and Regulation FD materials tied to the company's real estate portfolio and segment performance.
Other filings cover material financing arrangements, including credit-facility amendments and an at-the-market equity offering program, as well as proxy disclosures on board governance, executive compensation and stockholder voting matters. Leadership-transition reports and related compensatory arrangements are documented through Form 8-K and amended Form 8-K disclosures.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock, with an additional 1,215,000-share option, through a forward sale agreement with Royal Bank of Canada. The forward purchaser will borrow and sell the shares now, while the company expects to physically settle the agreement and receive cash proceeds within about 18 months, although it can instead choose cash or net share settlement, which could result in no proceeds and potential cash or share payments to the bank.
Shares outstanding were 178,164,566 as of November 14, 2025, and are expected to be 186,264,566 after full physical settlement. AHR continues to expand, having closed over $575 million of acquisitions in 2025 and holding a $288.5 million pipeline, supported by a $1.0 billion at-the-market program and prior forward sales for 2,153,436 shares.
American Healthcare REIT (AHR) executive Mark E. Foster (EVP, GC & Secretary) reported an open-market sale of 1,500 shares of common stock on 11/11/2025 at a $49.3531 weighted average price (Transaction Code: S).
The sale was executed in multiple trades between $49.35 and $49.37. Following the transaction, Foster beneficially owns 57,600 shares directly.
American Healthcare REIT (AHR) received a Form 144 notice indicating a planned sale of 1500 common shares. The filing lists an aggregate market value of 74030, with an approximate sale date of 11/11/2025 on the NYSE, using broker Merrill (8890 Lyra Drive, Columbus, OH).
The shares to be sold were acquired via Restricted Stock Vesting on 03/25/2025 in the amount of 1500. Over the prior three months, a related sale shows 3850 common shares with gross proceeds of 161156 by Mark Foster. The table also lists 176908238 shares outstanding.
Form 144 is a notice of intent to sell restricted or control securities and is an administrative disclosure rather than a financing transaction.
American Healthcare REIT, Inc. (AHR) received an amended Schedule 13G/A (Amendment No. 3) from Wellington affiliates reporting passive beneficial ownership. The filing lists 8,658,610 shares beneficially owned, representing 5.14% of the common stock as of the event date 09/30/2025.
Wellington reports 0 shares with sole voting or dispositive power, 6,564,421 with shared voting power, and 8,658,610 with shared dispositive power. The securities are held of record by clients of Wellington investment advisers, and no single client is known to hold more than five percent of the class.
American Healthcare REIT (AHR) director Jeffrey T. Hanson reported an open‑market sale of 20,010 shares of common stock on 11/10/2025 at a weighted average price of $49.6804 (Transaction Code S). Following the sale, he held 21,798 shares directly.
He also reports indirect holdings including 54,778 shares by the Hanson Family Trust, 5,552 by April L. Hanson IRA, 2,515 by Crescentridge 401(k), 16,720 by a Defined Benefit Pension Plan, 729 by spouse’s 401(k), and 4,869 by JTH Holdings LLC DBPP. Additionally, 1,268,643 OP Units are held by AHI Group Holdings, LLC; Mr. Hanson disclaims beneficial ownership except to his pecuniary interest.
American Healthcare REIT (AHR) filed a Form 144 notice for a proposed sale of 20,010 shares of common stock. The filing lists an aggregate market value of $994,105, to be transacted through Merrill, with the NYSE named as the exchange and an approximate sale date of 11/10/2025. Shares outstanding were 176,908,238.
The shares to be sold were acquired via restricted stock vesting on several dates, including 10/01/2023 (5,762), 06/15/2024 (3,025), 10/01/2024 (5,762), 02/09/2025 (1,851), and 11/07/2025 (3,610).
American Healthcare REIT, Inc. (AHR) reported a profitable Q3 2025. Total revenues were $572,937,000, up from $523,814,000 a year ago, driven by resident fees and services of $532,058,000. Net income attributable to controlling interest was $55,927,000, or $0.33 per basic and diluted share, compared with a loss in the prior-year quarter.
Expenses rose with property operating costs at $454,530,000 and depreciation and amortization at $49,181,000. Other items included an impairment of real estate investments of $3,768,000 and a gain on re-measurement of a previously held equity interest of $14,580,000. Interest expense, net improved to $20,392,000 from $30,395,000.
For the nine months, operating cash flow reached $239,276,000. The company executed acquisitions totaling $337,978,000 (15 properties) and dispositions of $56,454,000 (12 assets). Cash and cash equivalents increased to $147,364,000, while lines of credit and term loan, net declined to $549,696,000. Shares outstanding were 171,031,062 as of September 30, 2025; 176,908,238 were outstanding as of November 3, 2025.
American Healthcare REIT, Inc. (AHR) furnished an 8-K announcing its quarterly disclosures. The company released its earnings press release for the quarter ended September 30, 2025 and issued a Q3 2025 supplemental package.
The materials are provided under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD). Exhibits include 99.1 (Earnings Release) and 99.2 (Third Quarter 2025 Supplemental). The information in Items 2.02 and 7.01 is being furnished, not filed.
American Healthcare REIT, Inc. reported that its board of directors authorized a third quarter 2025 cash distribution for common stockholders. The distribution covers the period from July 1, 2025 through September 30, 2025 and is set at $0.25 per share, which the company states is equal to an annualized distribution rate of $1.00 per share. Stockholders of record as of the close of business on September 30, 2025 will be eligible to receive the payment. The company expects to pay the distribution in cash on or about October 17, 2025, and notes that it will be paid only from legally available funds.
Mark E. Foster, EVP, GC & Secretary of American Healthcare REIT, Inc. (AHR), reported the sale of 3,850 shares of the company's common stock on 09/03/2025 at an average price of $41.8887 per share, with transaction prices ranging from $41.84 to $41.92. After the sale, the reporting person beneficially owned 59,100 shares. The ownership total includes 1,059 shares newly acquired under the issuer's Employee Stock Purchase Plan, as disclosed in the form.
The filing is a Section 16 Form 4 reporting a non-derivative disposition by a company officer. The report includes an undertaking to provide, upon request, a breakdown of the number of shares sold at each separate price. No derivative transactions, amendments, or additional material terms are disclosed in this submission.